India, April 26 -- AbbVie Inc. (ABBV), while announcing higher first-quarter earnings, on Friday raised its outlook for fiscal 2024.
In pre-market activity on the NYSE, AbbVie shares were gaining around 1.7 percent to trade at $170.11.
For fiscal 2024, the company now expects adjusted earnings per share of $11.13 to $11.33, higher than previously expected $10.97 to $11.17 per share.
The outlook includes an unfavorable impact of $0.08 per share related to acquired IPR&D and milestones expense incurred during the first quarter 2024.
Analysts on average expect the company to earn $11.1 per share, according to figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items.
In its first quarter, AbbVie earnings inc...